{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:18Z","timestamp":1740126438209,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"French Ministry of Health","award":["PHRC AOM 09 195"],"award-info":[{"award-number":["PHRC AOM 09 195"]}]},{"name":"D\u00e9partement \u00e0 la Recherche Clinique et au D\u00e9veloppement"},{"DOI":"10.13039\/501100005897","name":"French Society of Dermatology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Little is known about phototype and the response to systemic treatment in psoriasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the characteristics of psoriasis, the therapeutic choice and its efficacy according to phototype.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We included patients from the PsoBioTeq cohort initiating a first biologic. Patients were classified according to their phototype. The evaluation included disease characteristics, choice of the initial biologic and therapeutic response at 12\u2005months based on 90% improvement from baseline in Psoriasis Area and Severity Index (PASI 90) and Dermatology Life Quality Index (DLQI) 0\/1.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 1400 patients included, 423 (30.2%), 904 (64.6%) and 73 (5.2%) were in the phototype I\u2013II, III\u2013IV and V\u2013VI groups, respectively. The V\u2013VI group had a higher initial DLQI, and more frequently initiated ustekinumab. Patients in the V\u2013VI group maintained the initial biologic prescribed as did the other phototype groups, even though the proportion of patients reaching PASI 90 and DLQI 0\/1 at 12\u2005months was lower in this group than the other groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patient phototype seems associated with quality of life and choice of the initial biologic in psoriasis. The phototype V\u2013VI group less frequently switched treatments than did the other groups when the response was not efficient.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llad233","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T10:20:34Z","timestamp":1688638834000},"page":"1238-1246","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohort"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4411-7289","authenticated-orcid":false,"given":"Romain","family":"Salle","sequence":"first","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Henri Mondor , Cr\u00e9teil , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Tubach","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, D\u00e9partement de Sant\u00e9 Publique, Centre de Pharmaco\u00e9pid\u00e9miologie (Cephepi) , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Arlegui","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, D\u00e9partement de Sant\u00e9 Publique, Centre de Pharmaco\u00e9pid\u00e9miologie (Cephepi) , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00eblle","family":"Curmin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, D\u00e9partement de Sant\u00e9 Publique, Centre de Pharmaco\u00e9pid\u00e9miologie (Cephepi) , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuelle","family":"Viguier","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, H\u00f4pital Robert Debr\u00e9, Centre Hospitalier Universitaire (CHU) de Reims , Reims , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-1229","authenticated-orcid":false,"given":"Marie","family":"Beylot-Barry","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 CHU de Bordeaux; and Bordeaux Institute of Oncology, INSERM U1312, Team 05, Universit\u00e9 de Bordeaux , Bordeaux , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3212-7455","authenticated-orcid":false,"given":"Alain","family":"Dupuy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, CHU de Rennes; Pharmacoepidemiology and Health Services Research, Universit\u00e9 de Rennes; and EHESP French School of Public Health , Rennes , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Beneton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Le Mans Hospital , Le Mans , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rouen University Hospital, INSERM U1234, CHU Rouen Normandie , Rouen , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"De Rycke","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, D\u00e9partement de Sant\u00e9 Publique, Centre de Pharmaco\u00e9pid\u00e9miologie (Cephepi) , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-7928","authenticated-orcid":false,"given":"Denis","family":"Jullien","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Edouard Herriot, Hospices Civils de Lyon , Lyon , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5780-1827","authenticated-orcid":false,"given":"Emmanuel","family":"Mah\u00e9","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Victor Dupouy, Argenteuil , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-5263","authenticated-orcid":false,"given":"Carle","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Dermatology, INSERM Infinity U1291, Paul Sabatier University , Toulouse , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Aleth","family":"Richard","sequence":"additional","affiliation":[{"name":"Department of Dermatology, CHU Marseille , Marseille , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-4384","authenticated-orcid":false,"given":"Herv\u00e9","family":"Bachelez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Saint-Louis, AP-HP; Universit\u00e9 Paris Diderot\/Universit\u00e9 Paris Cit\u00e9; and INSERM UMR1163, Institut Imagine , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Zago","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d\u2019\u00c9pid\u00e9miologie et de Sant\u00e9 Publique, AP-HP, H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, D\u00e9partement de Sant\u00e9 Publique, Centre de Pharmaco\u00e9pid\u00e9miologie (Cephepi) , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-4310","authenticated-orcid":false,"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Henri Mondor , Cr\u00e9teil , France"},{"name":"Facial Dermatosis Clinic, H\u00f4pital Universitaire Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France; and Universit\u00e9 Paris-Est Cr\u00e9teil (UPEC) , Cr\u00e9teil , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-5270","authenticated-orcid":false,"given":"\u00c9milie","family":"Sbidian","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Henri Mondor , Cr\u00e9teil , France"},{"name":"Clinical Investigation Centre, H\u00f4pital Henri Mondor , Cr\u00e9teil , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PsoBioTeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"2023102519561942400_llad233-B1","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"2023102519561942400_llad233-B2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation,\u00a0and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"2023102519561942400_llad233-B3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/bjd.17738","article-title":"Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta-analysis","volume":"181","author":"Mourad","year":"2019","journal-title":"Br J Dermatol"},{"key":"2023102519561942400_llad233-B4","first-page":"33","article-title":"Soleil et peau","volume":"2","author":"Fitzpatrick","year":"1975","journal-title":"J Med Esthet"},{"key":"2023102519561942400_llad233-B5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"key":"2023102519561942400_llad233-B6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clindermatol.2019.07.010","article-title":"Skin typing: Fitzpatrick grading and others","volume":"37","author":"Gupta","year":"2019","journal-title":"Clin Dermatol"},{"key":"2023102519561942400_llad233-B7","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jaad.2018.08.049","article-title":"Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience","volume":"80","author":"Alexis","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2023102519561942400_llad233-B8","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.12788\/j.sder.2018.027","article-title":"Treating acne in patients with skin of color","volume":"37","author":"Alexis","year":"2018","journal-title":"Semin Cutan Med Surg"},{"key":"2023102519561942400_llad233-B9","first-page":"30","article-title":"Pruritus in black skin: unique molecular characteristics and clinical features","volume":"113","author":"McColl","year":"2020","journal-title":"J Natl Med Assoc"},{"key":"2023102519561942400_llad233-B10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaad.2004.07.045","article-title":"The prevalence of psoriasis in African Americans: results from a population-based study","volume":"52","author":"Gelfand","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"2023102519561942400_llad233-B11","first-page":"16","article-title":"Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances","volume":"7","author":"Alexis","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"2023102519561942400_llad233-B12","first-page":"866","article-title":"A retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept","volume":"10","author":"Shah","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"2023102519561942400_llad233-B13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40257-018-0408-z","article-title":"Efficacy and safety of brodalumab in patients with moderate-to-severe plaque psoriasis and skin of color: results from the pooled AMAGINE-2\/-3 randomized trials","volume":"20","author":"McMichael","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"2023102519561942400_llad233-B14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2009.09.040","article-title":"Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis","volume":"63","author":"Menter","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2023102519561942400_llad233-B15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/bjd.16008","article-title":"Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: a pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies","volume":"178","author":"Gordon","year":"2018","journal-title":"Br J Dermatol"},{"key":"2023102519561942400_llad233-B16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/JNC.0000000000000260","article-title":"Measuring race among Latinos to address racism, discrimination, and HIV health inequities: comparing self-reported race and Fitzpatrick skin phototype","volume":"32","author":"Sheehan","year":"2021","journal-title":"J Assoc Nurses AIDS Care"},{"key":"2023102519561942400_llad233-B17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.0909-725X.2006.00167.x","article-title":"The difference between the constitutive and facultative skin color does not reflect skin phototype in Asian skin","volume":"12","author":"Choe","year":"2006","journal-title":"Skin Res Technol"},{"key":"2023102519561942400_llad233-B18","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/jdv.14406","article-title":"Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort","volume":"31","author":"Sbidian","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023102519561942400_llad233-B19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201750","article-title":"Pigmentation phototype and prostate and breast cancer in a select Spanish population \u2013 a Mendelian randomization analysis in the MCC-Spain study","volume":"13","author":"G\u00f3mez-Acebo","year":"2018","journal-title":"PLOS ONE"},{"author":"R Core Team","key":"2023102519561942400_llad233-B20"},{"key":"2023102519561942400_llad233-B21","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s10067-014-2763-3","article-title":"Psoriasis and psoriatic arthritis in African-American patients \u2013 the need to measure disease burden","volume":"34","author":"Kerr","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2023102519561942400_llad233-B22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13548506.2016.1220603","article-title":"Socioeconomic and sociocultural determinants of psychological distress and quality of life among patients with psoriasis in a selected multi-ethnic Malaysian population","volume":"22","author":"Kwan","year":"2017","journal-title":"Psychol Health Med"},{"key":"2023102519561942400_llad233-B23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40257-017-0332-7","article-title":"Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-white racial\/ethnic groups","volume":"19","author":"Kaufman","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"2023102519561942400_llad233-B24","first-page":"387","article-title":"Common dermatologic disorders in skin of color: a comparative practice survey","volume":"80","author":"Alexis","year":"2007","journal-title":"Cutis"},{"key":"2023102519561942400_llad233-B25","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/sj.jid.5700875","article-title":"Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients","volume":"127","author":"Nijsten","year":"2007","journal-title":"J Invest Dermatol"},{"key":"2023102519561942400_llad233-B26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjd.19876","article-title":"Biologics utilization for psoriasis is lower in black compared with white patients","volume":"185","author":"Hodges","year":"2021","journal-title":"Br J Dermatol"},{"key":"2023102519561942400_llad233-B27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamadermatol.2021.2599","article-title":"Association between biologics use and risk of serious infection in patients with psoriasis","volume":"157","author":"Penso","year":"2021","journal-title":"JAMA Dermatol"},{"key":"2023102519561942400_llad233-B28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamadermatol.2016.4129","article-title":"Diversity in dermatology clinical trials: a systematic review","volume":"153","author":"Charrow","year":"2017","journal-title":"JAMA Dermatol"},{"author":"L\u00e9gifrance","key":"2023102519561942400_llad233-B29"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad233\/51312366\/llad233.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/11\/1238\/52548697\/llad233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/11\/1238\/52548697\/llad233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T19:56:49Z","timestamp":1698263809000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/11\/1238\/7220077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,7,6]]},"published-print":{"date-parts":[[2023,10,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad233","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,7,6]]}}}